Pilot, open-label, single-arm clinical trial evaluating the efficacy of topical crisaborole for steroid refractory morphea

被引：3
|
作者：
Petty, Amy J. [1 ]
Emge, Drew A. [1 ]
Blanchard, Sarah K. [1 ]
Selim, Maria Angelica [2 ]
Scoggins, Kim [1 ]
Liu, Beiyu [3 ]
Green, Cynthia L. [3 ]
Cardones, Adela R. [4 ,5 ]
机构：
[1] Duke Univ, Dept Dermatol, Durham, NC USA
[2] Duke Univ, Dept Pathol, Div Dermatopathol, Durham, NC USA
[3] Duke Univ, Dept Biostat & Bioinformat, Sch Med, Durham, NC USA
[4] Univ Kansas, Med Ctr, Dept Internal Med, Div Dermatol, Kansas City, KS USA
[5] Univ Kansas, Med Ctr, Dept Internal Med, Div Dermatol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 02期
关键词：
clinical trial; crisaborole; fibrosis; morphea; PDE4; CHILDREN; SAFETY;
D O I：
10.1016/j.jaad.2023.03.052
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：390 / 392
页数：3
相关论文
共 50 条
  • [41] Efficacy and safety of generic pomalidomide plus low-dose dexamethasone in relapsed or refractory multiple myeloma: a multicenter, open-label, single-arm trial
    Huixing Zhou
    Yafei Wang
    Jiao Chen
    Aili He
    Jie Jin
    Quanyi Lu
    Ying Zhao
    Junjun Li
    Ming Hou
    Liping Su
    Xun Lai
    Wei Wang
    Lihong Liu
    Yanping Ma
    Da Gao
    Wenhong Lai
    Xin Zhou
    Hongmei Jing
    Jinqiao Zhang
    Wei Yang
    Xuehong Ran
    Congmeng Lin
    Jianping Hao
    Taiwu Xiao
    Zhenqian Huang
    Zhigang Zhu
    Qing Wang
    Baijun Fang
    Binghua Wang
    Yanping Song
    Zhen Cai
    Bo Liu
    Yanan Zhu
    Xinai Yang
    Xiaoyan Kang
    Juan Li
    Wenming Chen
    Annals of Hematology, 2024, 103 : 855 - 868
  • [42] Efficacy and safety of generic pomalidomide plus low-dose dexamethasone in relapsed or refractory multiple myeloma: a multicenter, open-label, single-arm trial
    Zhou, Huixing
    Wang, Yafei
    Chen, Jiao
    He, Aili
    Jin, Jie
    Lu, Quanyi
    Zhao, Ying
    Li, Junjun
    Hou, Ming
    Su, Liping
    Lai, Xun
    Wang, Wei
    Liu, Lihong
    Ma, Yanping
    Gao, Da
    Lai, Wenhong
    Zhou, Xin
    Jing, Hongmei
    Zhang, Jinqiao
    Yang, Wei
    Ran, Xuehong
    Lin, Congmeng
    Hao, Jianping
    Xiao, Taiwu
    Huang, Zhenqian
    Zhu, Zhigang
    Wang, Qing
    Fang, Baijun
    Wang, Binghua
    Song, Yanping
    Cai, Zhen
    Liu, Bo
    Zhu, Yanan
    Yang, Xinai
    Kang, Xiaoyan
    Li, Juan
    Chen, Wenming
    ANNALS OF HEMATOLOGY, 2024, 103 (03) : 855 - 868
  • [43] Open-Label, Single-Center, Single-Arm Study Evaluating the Efficacy and Safety of Elobixibat for Chronic Constipation in Patients With Heart Failure
    Fujisue, Koichiro
    Ito, Miwa
    Matsuzawa, Yasushi
    Arima, Yuichiro
    Takashio, Seiji
    Sueta, Daisuke
    Araki, Satoshi
    Hanatani, Shinsuke
    Yamanaga, Kenshi
    Yamamoto, Masahiro
    Kaneko, Shozo
    Yamamoto, Eiichiro
    Matsushita, Kenichi
    Soejima, Hirofumi
    Tsujita, Kenichi
    CIRCULATION REPORTS, 2024, 6 (03) : 55 - 63
  • [44] A Single-arm Open-label Prospective Trial on the Efficacy of Loha Churna Vatakam on Hb% in Iron Deficiency Anemia (Pandu)
    Gupta, Shweta
    Vinayak, Joshi Mrudula
    Gupta, Navneet Kumar
    Bhatt, Abhishek
    ASIAN JOURNAL OF PHARMACEUTICAL RESEARCH AND HEALTH CARE, 2024, 16 (04) : 461 - 465
  • [45] An open-label, single-arm study assessing safety and efficacy of panitumumab in patients with metastatic colorectal cancer refractory to standard chemotherapy
    Van Cutsem, E.
    Siena, S.
    Humblet, Y.
    Canon, J. -L.
    Maurel, J.
    Bajetta, E.
    Neyns, B.
    Kotasek, D.
    Santoro, A.
    Scheithauer, W.
    Spadafora, S.
    Amado, R. G.
    Hogan, N.
    Peeters, M.
    ANNALS OF ONCOLOGY, 2008, 19 (01) : 92 - 98
  • [46] Efficacy and Safety of Apatinib in Relapsed or Refractory Diffuse Large B Cell Lymphoma: An Open-Label, Single-Arm, Prospective Study
    Ma, Xinran
    Li, Ling
    Zhang, Lei
    Li, Xin
    Fu, Xiaorui
    Wang, Xinhua
    Wu, Jingjing
    Zhang, Xudong
    Feng, Xiaoyan
    Zhou, Zhiyuan
    Chang, Yu
    Li, Zhaoming
    Young, Ken H.
    Zhang, Mingzhi
    BLOOD, 2019, 134
  • [47] Use of Gefitinib in EGFR-Amplified Refractory Solid Tumors: An Open-Label, Single-Arm, Single-Center Prospective Pilot Study
    Seonggyu Byeon
    Jung Yong Hong
    Jeeyun Lee
    Do-Hyun Nam
    Se Hoon Park
    Joon Oh Park
    Young Suk Park
    Ho Yeong Lim
    Won Ki Kang
    Seung Tae Kim
    Targeted Oncology, 2020, 15 : 185 - 192
  • [48] An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma
    Izutsu, Koji
    Makita, Shinichi
    Nosaka, Kisato
    Yoshimitsu, Makoto
    Utsunomiya, Atae
    Kusumoto, Shigeru
    Morishima, Satoko
    Tsukasaki, Kunihiro
    Kawamata, Toyotaka
    Ono, Takaaki
    Rai, Shinya
    Katsuya, Hiroo
    Ishikawa, Jun
    Yamada, Hironori
    Kato, Kazunobu
    Tachibana, Masaya
    Kakurai, Yasuyuki
    Adachi, Nobuaki
    Tobinai, Kensei
    Yonekura, Kentaro
    Ishitsuka, Kenji
    BLOOD, 2023, 141 (10) : 1159 - 1168
  • [49] Use of Gefitinib in EGFR-Amplified Refractory Solid Tumors: An Open-Label, Single-Arm, Single-Center Prospective Pilot Study
    Byeon, Seonggyu
    Hong, Jung Yong
    Lee, Jeeyun
    Nam, Do-Hyun
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kang, Won Ki
    Kim, Seung Tae
    TARGETED ONCOLOGY, 2020, 15 (02) : 185 - 192
  • [50] Efficacy and safety of rifampicin-based triple therapy for non-puerperal mastitis: A single-arm, open-label, prospective clinical trial
    Zhou, Fei
    Li, Huanjie
    Wang, Fei
    Liu, Liyuan
    Yu, Lixiang
    Xiang, Yujuan
    Zheng, Chao
    Huang, Shuya
    Yu, Zhigang
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2024, 140 : 25 - 30
12345